Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010–21.

Article  PubMed  Google Scholar 

Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210–5.

Article  PubMed  Google Scholar 

Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. Esophageal carcinoma: towards targeted therapies. Cell Oncol (Dordr). 2020;43(2):195–209.

Article  PubMed  Google Scholar 

Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154(2):360–73.

Article  PubMed  Google Scholar 

Lagergren J, Lagergren P. Oesophageal cancer. BMJ. 2010;341(1): c6280.

Article  PubMed  Google Scholar 

Ito T, Tanabe K, Yamada H, Hatta H, Nishimoto S. Radiation- and photo-induced activation of 5-fluorouracil prodrugs as a strategy for the selective treatment of solid tumors. Molecules. 2008;13(10):2370–84.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Focaccetti C, Bruno A, Magnani E, Bartolini D, Principi E, Dallaglio K, et al. Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes. PLoS ONE. 2015;10(2): e0115686.

Article  PubMed  PubMed Central  Google Scholar 

Arnold CN, Goel A, Boland CR. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. Int J Cancer. 2003;106(1):66–73.

Article  PubMed  CAS  Google Scholar 

Shi X, Liu S, Kleeff J, Friess H, Buchler MW. Acquired resistance of pancreatic cancer cells towards 5-Fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes. Oncology. 2002;62(4):354–62.

Article  PubMed  CAS  Google Scholar 

Grem JL. Screening for dihydropyrimidine dehydrogenase deficiency. Clin Cancer Res. 2005;14:5067–8.

Article  Google Scholar 

Van Triest B, Pinedo HM, Van Hensbergen Y, Smid K, Telleman F, Schoenmakers PS, et al. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. Clin Cancer Res. 1999;5(3):643–54.

PubMed  Google Scholar 

Thompson B, Townsley F, Rosin-Arbesfeld R, Musisi H, Bienz M. A new nuclear component of the Wnt signalling pathway. Nat Cell Biol. 2002;4(5):367–73.

Article  PubMed  CAS  Google Scholar 

Esposito I, Cassaro A. PYGO2 (pygopus family PHD finger 2). Atlas Genet Cytogenet Oncol Haematol. 2020;24(4):159–63.

Google Scholar 

Zhang D, Liu Y, Wu Q, Zheng Y, Kaweme NM, Zhang Z, et al. Pygo2 as a novel biomarker in gastric cancer for monitoring drug resistance by upregulating MDR1. J Cancer. 2021;12(10):2952–9.

Article  PubMed  PubMed Central  Google Scholar 

Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer. 2020;19:1–24.

Article  Google Scholar 

Moghbeli M, Abbaszadegan MR, Farshchian M, Montazer M, Raeisossadati R, Abdollahi A, et al. Association of PYGO2 and EGFR in esophageal squamous cell carcinoma. Med Oncol. 2013;30(2):516.

Article  PubMed  Google Scholar 

Chen J, Luo Q, Yuan Y, Huang X, Cai W, Li C, et al. Pygo2 associates with MLL2 histone methyltransferase and GCN5 histone acetyltransferase complexes to augment Wnt target gene expression and breast cancer stem-like cell expansion. Mol Cell Biol. 2010;30(24):5621–35.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bian J, Dannappel M, Wan C, Firestein R. Transcriptional regulation of Wnt/β-catenin pathway in colorectal cancer. Cells. 2020;9(9):2125.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu Y, Dong QZ, Wang S, Fang CQ, Miao Y, Wang L, et al. Abnormal expression of Pygopus 2 correlates with a malignant phenotype in human lung cancer. BMC Cancer. 2013;13:346.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhou C, Cheng H, Qin W, Zhang Y, Xiong H, Yang J, et al. Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells. Oncotarget. 2017;8(17):27915–28.

Article  PubMed  PubMed Central  Google Scholar 

Iannozzi NT, Burroughs Garcia J, Marchica V, Franceschi V, Toscani D, Vescovini R, et al. PYGO2-MDR1 axis in multiple myeloma patients with 1q21 amplification as promising target to overcome carfilzomib resistance. Blood. 2023;142:6575.

Article  Google Scholar 

Ardalan Moghadam Al F, Forghanifard MM, Zarrinpour V. PYGO2 increases proliferation and migration capacities through critical signaling pathways in esophageal squamous cell carcinoma. J Biochem Mol Toxicol. 2024;38(1):e23625.

Article  PubMed  CAS  Google Scholar 

Sahab-Negah S, Ariakia F, Jalili-Nik M, Afshari AR, Salehi S, Samini F, et al. Curcumin loaded in niosomal nanoparticles improved the anti-tumor effects of free curcumin on glioblastoma stem-like cells: an in vitro study. Mol Neurobiol. 2020;57(8):3391–411.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer. 2007;6:24.

Article  PubMed  PubMed Central  Google Scholar 

Soleymani S, Khales SA, Jafarian AH, Kalat HR, Forghanifard MM. PYGO2 as an independent diagnostic marker expressed in a majority of colorectal cancers. J Histotechnol. 2019;42(3):98–103.

Article  PubMed  CAS  Google Scholar 

Liang Y, Wang C, Chen A, Zhu L, Zhang J, Jiang P, et al. Immunohistochemistry analysis of Pygo2 expression in central nervous system tumors. J Cell Commun Signal. 2019;13(1):75–84.

Article  PubMed  Google Scholar 

Moghbeli M, Sadrizadeh A, Forghanifard MM, Mozaffari HM, Golmakani E, Abbaszadegan MR. Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion. J Cell Commun Signal. 2016;10(1):49–53.

Article  PubMed  Google Scholar 

Talla SB, Brembeck FH. The role of Pygo2 for Wnt/ss-catenin signaling activity during intestinal tumor initiation and progression. Oncotarget. 2016;7(49):80612–32.

Article  PubMed  PubMed Central  Google Scholar 

van Tienen LM, Mieszczanek J, Fiedler M, Rutherford T, Bienz M. Correction: constitutive scaffolding of multiple Wnt enhanceosome components by legless/BCL9. Elife. 2017. https://doi.org/10.7554/eLife.27150.

Article  PubMed  PubMed Central  Google Scholar 

Zhou C, Yi C, Yi Y, Qin W, Yan Y, Dong X, et al. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/beta-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes. Mol Cancer. 2020;19(1):118.

Article  PubMed  PubMed Central  CAS  Google Scholar 

De D, Chen A, Wu Z, Lv S, He G, Qi Y. Overexpression of pygopus2 protects HeLa cells from vinblastine-induced apoptosis. Biol Chem. 2009;390(2):157–65.

Article  PubMed  CAS  Google Scholar 

Zhang ZM, Wu JF, Luo QC, Liu QF, Wu QW, Ye GD, et al. Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/beta-catenin pathway. Oncogene. 2016;35(36):4787–97.

Article  PubMed  CAS  Google Scholar 

Flahaut M, Meier R, Coulon A, Nardou K, Niggli F, Martinet D, et al. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway. Oncogene. 2009;28(23):2245–56.